프로브 재처리 시장 규모, 점유율, 동향 분석 리포트 : 프로브 분류별, 프로브 유형별, 제품별, 방법별, 최종 용도별, 지역별, 부문 예측(2025-2030년)

Probe Reprocessing Market Size & Trends:

The global probe reprocessing market size was valued at USD 844.87 million in 2024 and is anticipated to grow at a CAGR of 10.55% from 2025 to 2030. The growth can be attributed to the increasing prevalence of Hospital-acquired Infections (HAIs), growing awareness about the importance of infection control, and stringent regulatory guidelines set by health authorities. With the rise in the use of medical probes in diagnostic imaging, endoscopy, and other procedures, the demand for proper cleaning, disinfection, and sterilization of these devices has significantly increased to prevent cross-contamination.

The rising demand for ultrasound procedures is projected to drive the growth of the probe reprocessing industry in the coming years. There is also an increasing need for research on the utilization of ultrasound technologies. For example, a study published by the National Library of Medicine in August 2022 analyzed ultrasound usage within the radiology department at Tygerberg Hospital (TBH). This study compared ultrasound volumes from 2013 to 2019, revealing a 12% increase in utilization. Ultrasound remained the second-most frequently performed specialized imaging procedure after computed tomography.

Moreover, the growing use of echocardiograms-ultrasound-based examinations of the heart-for cardiac diagnostics, driven by the rising prevalence of cardiovascular diseases, is expected to fuel the demand for ultrasound procedures. According to data released by MedStar Health in January 2024, over 7 million echocardiograms are conducted annually in the U.S. As a result, the rising need for cardiac ultrasound is anticipated to increase the demand for phased array or cardiac probes, further driving the need for probe reprocessing solutions to meet this growing demand.

In addition, technological advancements, including the development of high-level disinfectants and automated probe reprocessing systems, are expected to further propel market expansion. Key industry players, such as CS Medical LLC and Nanosonics, are introducing innovative solutions. For instance, in November 2022, Nanosonics launched four new products targeting the UK and Ireland markets: the Wireless Probe Holder, AuditPro, Soluscope Serie-TEE, and the UPS Bracket. AuditPro is a digital infection control management solution designed to enhance traceability and compliance. It is available in tailored versions such as the AuditPro Digital Logbook and AuditPro Infection Control Management Solution.

Moreover, the increasing emphasis on automation in probe reprocessing is expected to create significant opportunities for industry participants. Automated systems are gaining traction due to several advantages, including minimizing the risk of human error and inconsistencies across disinfection cycles, reducing the need for manual staff involvement, lowering personal protective equipment (PPE) requirements, improving compliance with standard operating procedures (SOPs), and streamlining workflows for easier scalability across healthcare departments.

Global Probe Reprocessing Market Report Segmentation

This report forecasts revenue growth at the global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2018 to 2030. For this study, Grand View Research has segmented the global probe reprocessing market report on the basis of probe classification, probe type, product type, method, and end use and region:

• Probe Classification Outlook (Revenue, USD Million, 2018 - 2030)
• Semi-Critical
• Non-Critical
• Critical
• Probe Type Outlook (Revenue, USD Million, 2018 - 2030)
• Convex Probes
• Linear Probes
• Transesophageal (TEE) Probes
• Phased Array/Cardiac Probes
• Endocavitary Probes
• Others
• Product Outlook (Revenue, USD Million, 2018 - 2030)
• Instruments
  • Automated Reprocessors
  • UV-C Disinfectors
  • Manual Reprocessors/Soaking Stations
  • Ultrasound Probe Storage Cabinets
• Consumables
  • Formulations
  • Disinfectant Liquids
  • Disinfectant Wipes
  • Disinfectant Sprays
  • Detergent
  • Enzymatic Detergents
  • Non-enzymatic Detergents
• Service
• Method Outlook (Revenue, USD Million, 2018 - 2030)
• Sterilization
• High-Level Disinfection
• Intermediate Level Disinfection
• Low-Level Disinfection
• End Use Outlook (Revenue, USD Million, 2018 - 2030)
• Hospitals and Clinics
• Diagnostic Imaging Centers
• Others
• Regional Outlook (Revenue, USD Million, 2018 - 2030)
• North America
  • U.S.
  • Canada
  • Mexico
• Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Norway
  • Denmark
  • Sweden
• Asia Pacific
  • Japan
  • China
  • India
  • Australia
  • South Korea
  • Thailand
• Latin America
  • Brazil
  • Argentina
• Middle East and Africa (MEA)
  • South Africa
  • Saudi Arabia
  • UAE
  • Kuwait

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation and Scope
• 1.2. Segment Definitions
  • 1.2.1. Probe classification
  • 1.2.2. Probe Type
  • 1.2.3. Product Type
  • 1.2.4. Method
  • 1.2.5. End Use
  • 1.2.6. Estimates and forecasts timeline
• 1.3. Research Methodology
• 1.4. Information Procurement
  • 1.4.1. Purchased database
  • 1.4.2. GVR's internal database
  • 1.4.3. Secondary sources
  • 1.4.4. Primary research
  • 1.4.5. Details of primary research
• 1.5. Information or Data Analysis
  • 1.5.1. Data analysis models
• 1.6. Market Formulation & Validation
• 1.7. Model Details
  • 1.7.1. Commodity flow analysis (Model 1)
  • 1.7.2. Approach 1: Commodity flow approach
  • 1.7.3. Volume price analysis (Model 2)
  • 1.7.4. Approach 2: Volume price analysis
• 1.8. List of Secondary Sources
• 1.9. List of Primary Sources
• 1.10. Objectives

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Outlook
• 2.3. Regional outlook
• 2.4. Competitive Insights

Chapter 3. Probe Reprocessing Variables, Trends & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent Market Outlook
  • 3.1.2. Related/ancillary market outlook
• 3.2. Market Dynamics
  • 3.2.1. Market Driver Analysis
    • 3.2.1.1. Growing Demand For Ultrasound Procedures
    • 3.2.1.2. Rising Incidence of Hospital-Acquired Infections
    • 3.2.1.3. Development Of Advanced Products
  • 3.2.2. Market Restraint Analysis
    • 3.2.2.1. Recalls Of Probe Reprocessing Products
• 3.3. Probe Reprocessing Analysis Tools
  • 3.3.1. Industry Analysis - Porter's
    • 3.3.1.1. Bargaining power of suppliers
    • 3.3.1.2. Bargaining power of buyers
    • 3.3.1.3. Threat of substitutes
    • 3.3.1.4. Threat of new entrants
    • 3.3.1.5. Competitive rivalry
  • 3.3.2. PESTEL Analysis
    • 3.3.2.1. Political landscape
    • 3.3.2.2. Economic landscape
    • 3.3.2.3. Social landscape
    • 3.3.2.4. Technological landscape
    • 3.3.2.5. Environmental landscape
    • 3.3.2.6. Legal landscape

Chapter 4. Probe Reprocessing Market - Segment Analysis, by Probe Classification, 2018 - 2030 (USD Million)

• 4.1. Probe Reprocessing Market: Probe Classification Outlook and Key Takeaways
• 4.2. Probe Reprocessing Market: Probe Classification Movement Analysis
• 4.3. Probe Reprocessing Market Estimates & Forecast, by Probe Classification (USD Million)
• 4.4. Critical
  • 4.4.1. Critical Market, 2018 - 2030 (USD Million)
• 4.5. Semi-Critical
  • 4.5.1. Semi Critical Market, 2018 - 2030 (USD Million)
• 4.6. Non-Critical
  • 4.6.1. Non-critical Market, 2018 - 2030 (USD Million)

Chapter 5. Probe Reprocessing Market - Segment Analysis, by Probe Type, 2018 - 2030 (USD Million)

• 5.1. Probe Reprocessing Market: Probe Type Outlook and Key Takeaways
• 5.2. Probe Reprocessing Market: Probe Type Movement Analysis
• 5.3. Probe Reprocessing Market Estimates & Forecast, by Probe Type (USD Million)
• 5.4. Convex Probes
  • 5.4.1. Convex Probes Market, 2018 - 2030 (USD Million)
• 5.5. Linear Probe (Non-critical)
  • 5.5.1. Linear Probe Market, 2018 - 2030 (USD Million)
• 5.6. Transesophageal (TEE) Probe
  • 5.6.1. Transesophageal Market, 2018 - 2030 (USD Million)
• 5.7. Phased Array/Cardiac Probe
  • 5.7.1. Phased Array/Cardiac Probe Market, 2018 - 2030 (USD Million)
• 5.8. Endocavitary Probe
  • 5.8.1. Endocavitary Probe Market, 2018 - 2030 (USD Million)
• 5.9. Others
  • 5.9.1. Others Market, 2018 - 2030 (USD Million)

Chapter 6. Probe Reprocessing Market - Segment Analysis, by Product Type, 2018 - 2030 (USD Million)

• 6.1. Probe Reprocessing Market: Product Type Outlook and Key Takeaways
• 6.2. Probe Reprocessing Market: Product Type Movement Analysis
• 6.3. Probe Reprocessing Market Estimates & Forecast, by Product Type (USD Million)
• 6.4. Instruments
  • 6.4.1. Instruments Market, 2018 - 2030 (USD Million)
  • 6.4.2. Automated Reprocessors
    • 6.4.2.1. Automated Reprocessor Market, 2018 - 2030 (USD Million)
  • 6.4.3. UV-C Disinfectors
    • 6.4.3.1. UV-C disinfectors Market, 2018 - 2030 (USD Million)
  • 6.4.4. Manual Reprocessors/Soaking Stations
    • 6.4.4.1. Manual Reprocessors/Soaking Stations Market, 2018 - 2030 (USD Million)
  • 6.4.5. Ultrasound Probe Storage Cabinets
    • 6.4.5.1. Ultrasound Probe Storage Cabinets Market, 2018 - 2030 (USD Million)
• 6.5. Consumables
  • 6.5.1. Consumables Market, 2018 - 2030 (USD Million)
    • 6.5.1.1. Formulations
      • 6.5.1.1.1. Formulations Market, 2018 - 2030 (USD Million)
      • 6.5.1.1.2. Disinfectant Wipes
        • 6.5.1.1.2.1. Disinfectant Wipes Market, 2018 - 2030 (USD Million)
      • 6.5.1.1.3. Disinfectant Liquids
        • 6.5.1.1.3.1. Disinfectant Liquids Market, 2018 - 2030 (USD Million)
      • 6.5.1.1.4. Disinfectant Sprays
        • 6.5.1.1.4.1. Disinfectant Sprays Market, 2018 - 2030 (USD Million)
    • 6.5.1.2. Detergent
      • 6.5.1.2.1. Detergent Market, 2018 - 2030 (USD Million)
      • 6.5.1.2.2. Enzymatic Detergents
        • 6.5.1.2.2.1. Enzymatic Detergents Market, 2018 - 2030 (USD Million)
      • 6.5.1.2.3. Non-Enzymatic Detergents
        • 6.5.1.2.3.1. Non-Enzymatic Detergents Market, 2018 - 2030 (USD Million)
• 6.6. Service
  • 6.6.1. Service Market, 2018 - 2030 (USD Million)

Chapter 7. Probe Reprocessing Market - Segment Analysis, by Method, 2018 - 2030 (USD Million)

• 7.1. Probe Reprocessing Market: Method Outlook and Key Takeaways
• 7.2. Probe Reprocessing Market: Method Movement Analysis
• 7.3. Probe Reprocessing Market Estimates & Forecast, by Method (USD Million)
• 7.4. Sterilization
  • 7.4.1. Sterilization Market, 2018 - 2030 (USD Million)
• 7.5. High-Level Disinfection
  • 7.5.1. High-Level Disinfection Market, 2018 - 2030 (USD Million)
• 7.6. Intermediate Level Disinfection
  • 7.6.1. Intermediate Level Disinfection Market, 2018 - 2030 (USD Million)
• 7.7. Low-Level Disinfection
  • 7.7.1. Low-Level Disinfection Market, 2018 - 2030 (USD Million)

Chapter 8. Probe Reprocessing Market - Segment Analysis, by End Use, 2018 - 2030 (USD Million)

• 8.1. Probe Reprocessing Market: End Use Outlook and Key Takeaways
• 8.2. Probe Reprocessing Market: End Use Movement Analysis
• 8.3. Probe Reprocessing Market Estimates & Forecast, by End Use (USD Million)
• 8.4. Hospitals and Clinics
  • 8.4.1. Hospitals and Clinics Market, 2018 - 2030 (USD Million)
• 8.5. Diagnostics Imaging Centers
  • 8.5.1. Diagnostics Imaging Centers Market, 2018 - 2030 (USD Million)
• 8.6. Others
  • 8.6.1. Others Market, 2018 - 2030 (USD Million

Chapter 9. Probe Reprocessing Market: Regional Estimates & Trend Analysis

• 9.1. Regional Dashboard
• 9.2. Market Size & Forecasts Trend Analysis, 2018 to 2030:
• 9.3. North America
  • 9.3.1. U.S.
    • 9.3.1.1. Key country dynamics
    • 9.3.1.2. Regulatory framework/ reimbursement structure
    • 9.3.1.3. Competitive scenario
    • 9.3.1.4. U.S. market estimates and forecasts 2018 to 2030 (USD Million)
  • 9.3.2. Canada
    • 9.3.2.1. Key country dynamics
    • 9.3.2.2. Regulatory framework/ reimbursement structure
    • 9.3.2.3. Competitive scenario
    • 9.3.2.4. Canada market estimates and forecasts 2018 to 2030 (USD Million)
  • 9.3.3. Mexico
    • 9.3.3.1. Key country dynamics
    • 9.3.3.2. Regulatory framework/ reimbursement structure
    • 9.3.3.3. Competitive scenario
    • 9.3.3.4. Mexico market estimates and forecasts 2018 to 2030 (USD Million)
• 9.4. Europe
  • 9.4.1. UK
    • 9.4.1.1. Key country dynamics
    • 9.4.1.2. Regulatory framework/ reimbursement structure
    • 9.4.1.3. Competitive scenario
    • 9.4.1.4. UK market estimates and forecasts 2018 to 2030 (USD Million)
  • 9.4.2. Germany
    • 9.4.2.1. Key country dynamics
    • 9.4.2.2. Regulatory framework/ reimbursement structure
    • 9.4.2.3. Competitive scenario
    • 9.4.2.4. Germany market estimates and forecasts 2018 to 2030 (USD Million)
  • 9.4.3. France
    • 9.4.3.1. Key country dynamics
    • 9.4.3.2. Regulatory framework/ reimbursement structure
    • 9.4.3.3. Competitive scenario
    • 9.4.3.4. France market estimates and forecasts 2018 to 2030 (USD Million)
  • 9.4.4. Italy
    • 9.4.4.1. Key country dynamics
    • 9.4.4.2. Regulatory framework/ reimbursement structure
    • 9.4.4.3. Competitive scenario
    • 9.4.4.4. Italy market estimates and forecasts 2018 to 2030 (USD Million)
  • 9.4.5. Spain
    • 9.4.5.1. Key country dynamics
    • 9.4.5.2. Regulatory framework/ reimbursement structure
    • 9.4.5.3. Competitive scenario
    • 9.4.5.4. Spain market estimates and forecasts 2018 to 2030 (USD Million)
  • 9.4.6. Norway
    • 9.4.6.1. Key country dynamics
    • 9.4.6.2. Regulatory framework/ reimbursement structure
    • 9.4.6.3. Competitive scenario
    • 9.4.6.4. Norway market estimates and forecasts 2018 to 2030 (USD Million)
  • 9.4.7. Sweden
    • 9.4.7.1. Key country dynamics
    • 9.4.7.2. Regulatory framework/ reimbursement structure
    • 9.4.7.3. Competitive scenario
    • 9.4.7.4. Sweden market estimates and forecasts 2018 to 2030 (USD Million)
  • 9.4.8. Denmark
    • 9.4.8.1. Key country dynamics
    • 9.4.8.2. Regulatory framework/ reimbursement structure
    • 9.4.8.3. Competitive scenario
    • 9.4.8.4. Denmark market estimates and forecasts 2018 to 2030 (USD Million)
• 9.5. Asia Pacific
  • 9.5.1. Japan
    • 9.5.1.1. Key country dynamics
    • 9.5.1.2. Regulatory framework/ reimbursement structure
    • 9.5.1.3. Competitive scenario
    • 9.5.1.4. Japan market estimates and forecasts 2018 to 2030 (USD Million)
  • 9.5.2. China
    • 9.5.2.1. Key country dynamics
    • 9.5.2.2. Regulatory framework/ reimbursement structure
    • 9.5.2.3. Competitive scenario
    • 9.5.2.4. China market estimates and forecasts 2018 to 2030 (USD Million)
  • 9.5.3. India
    • 9.5.3.1. Key country dynamics
    • 9.5.3.2. Regulatory framework/ reimbursement structure
    • 9.5.3.3. Competitive scenario
    • 9.5.3.4. India market estimates and forecasts 2018 to 2030 (USD Million)
  • 9.5.4. Australia
    • 9.5.4.1. Key country dynamics
    • 9.5.4.2. Regulatory framework/ reimbursement structure
    • 9.5.4.3. Competitive scenario
    • 9.5.4.4. Australia market estimates and forecasts 2018 to 2030 (USD Million)
  • 9.5.5. South Korea
    • 9.5.5.1. Key country dynamics
    • 9.5.5.2. Regulatory framework/ reimbursement structure
    • 9.5.5.3. Competitive scenario
    • 9.5.5.4. South Korea market estimates and forecasts 2018 to 2030 (USD Million)
  • 9.5.6. Thailand
    • 9.5.6.1. Key country dynamics
    • 9.5.6.2. Regulatory framework/ reimbursement structure
    • 9.5.6.3. Competitive scenario
    • 9.5.6.4. Thailand market estimates and forecasts 2018 to 2030 (USD Million)
• 9.6. Latin America
  • 9.6.1. Brazil
    • 9.6.1.1. Key country dynamics
    • 9.6.1.2. Regulatory framework/ reimbursement structure
    • 9.6.1.3. Competitive scenario
    • 9.6.1.4. Brazil market estimates and forecasts 2018 to 2030 (USD Million)
  • 9.6.2. Argentina
    • 9.6.2.1. Key country dynamics
    • 9.6.2.2. Regulatory framework/ reimbursement structure
    • 9.6.2.3. Competitive scenario
    • 9.6.2.4. Argentina market estimates and forecasts 2018 to 2030 (USD Million)
• 9.7. MEA
  • 9.7.1. South Africa
    • 9.7.1.1. Key country dynamics
    • 9.7.1.2. Regulatory framework/ reimbursement structure
    • 9.7.1.3. Competitive scenario
    • 9.7.1.4. South Africa market estimates and forecasts 2018 to 2030 (USD Million)
  • 9.7.2. Saudi Arabia
    • 9.7.2.1. Key country dynamics
    • 9.7.2.2. Regulatory framework/ reimbursement structure
    • 9.7.2.3. Competitive scenario
    • 9.7.2.4. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Million)
  • 9.7.3. UAE
    • 9.7.3.1. Key country dynamics
    • 9.7.3.2. Regulatory framework/ reimbursement structure
    • 9.7.3.3. Competitive scenario
    • 9.7.3.4. UAE market estimates and forecasts 2018 to 2030 (USD Million)
  • 9.7.4. Kuwait
    • 9.7.4.1. Key country dynamics
    • 9.7.4.2. Regulatory framework/ reimbursement structure
    • 9.7.4.3. Competitive scenario
    • 9.7.4.4. Kuwait market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 10. Competitive Landscape

• 10.1. Market Participant Categorization
• 10.2. Recent Developments & Impact Analysis by Key Market Participants
• 10.3. Company Market Share Analysis, 2024
• 10.4. Key Company Profiles
  • 10.4.1. Nanosonics
    • 10.4.1.1. Company overview
    • 10.4.1.2. Financial performance
    • 10.4.1.3. Product benchmarking
    • 10.4.1.4. Strategic initiatives
  • 10.4.2. CIVCO Medical Solutions
    • 10.4.2.1. Company overview
    • 10.4.2.2. Financial performance
    • 10.4.2.3. Product benchmarking
    • 10.4.2.4. Strategic initiatives
  • 10.4.3. Tristel Plc
    • 10.4.3.1. Company overview
    • 10.4.3.2. Financial performance
    • 10.4.3.3. Product benchmarking
    • 10.4.3.4. Strategic initiatives
  • 10.4.4. Ecolab
    • 10.4.4.1. Company overview
    • 10.4.4.2. Financial performance
    • 10.4.4.3. Product benchmarking
    • 10.4.4.4. Strategic initiatives
  • 10.4.5. Germitec
    • 10.4.5.1. Company overview
    • 10.4.5.2. Financial performance
    • 10.4.5.3. Product benchmarking
    • 10.4.5.4. Strategic initiatives
  • 10.4.6. CS Medical LLC
    • 10.4.6.1. Company overview
    • 10.4.6.2. Financial performance
    • 10.4.6.3. Product benchmarking
    • 10.4.6.4. Strategic initiatives
  • 10.4.7. ASP (Fortive Corporation)
    • 10.4.7.1. Company overview
    • 10.4.7.2. Financial performance
    • 10.4.7.3. Product benchmarking
    • 10.4.7.4. Strategic initiatives
  • 10.4.8. Steelco S.p.A.
    • 10.4.8.1. Company overview
    • 10.4.8.2. Financial performance
    • 10.4.8.3. Product benchmarking
    • 10.4.8.4. Strategic initiatives
  • 10.4.9. Metrex Research, LLC
    • 10.4.9.1. Company overview
    • 10.4.9.2. Financial performance
    • 10.4.9.3. Product benchmarking
    • 10.4.9.4. Strategic initiatives
  • 10.4.10. STERIS
    • 10.4.10.1. Company overview
    • 10.4.10.2. Financial performance
    • 10.4.10.3. Product benchmarking
    • 10.4.10.4. Strategic initiatives